TROVAGENE ONCOLOGY
Dead / Cancelled — Cancelled — Section 8 (as of 26 Dec 2025)
What this means for you
This registration has been cancelled; it no longer blocks anyone on its own. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 88129656
- Registration number
- 5777693
- Mark type
- Design + words
- Filed
- 24 Sept 2018
- Published for opposition
- 15 Jan 2019
- Registered
- 11 Jun 2019
- Attorney of record
- Brian M. Davis
Goods and services
- Class 042 — Scientific and technological services: Pharmaceutical products development; Research and development in the pharmaceutical and biotechnology fields; Research and development of pharmaceuticals for the treatment of cancer; Medical and scientific research in the field of cancer treatment and diagnosis; Pharmaceutical research and development
Owner
- Trovagene, Inc., San Diego, CA, US
- Trovagene, Inc., San Diego, CA, US
- Trovagene, Inc., San Diego, CA, US
Prior registrations
Prosecution history
- 26 Dec 2025 — CANCELLED SEC. 8 (6-YR)
- 11 Jun 2024 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 11 Jun 2019 — REGISTERED-PRINCIPAL REGISTER
- 07 May 2019 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 06 May 2019 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 06 May 2019 — ASSIGNED TO EXAMINER
- 06 Apr 2019 — STATEMENT OF USE PROCESSING COMPLETE
- 20 Mar 2019 — USE AMENDMENT FILED
- 06 Apr 2019 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 20 Mar 2019 — TEAS STATEMENT OF USE RECEIVED
- 12 Mar 2019 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 15 Jan 2019 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 15 Jan 2019 — PUBLISHED FOR OPPOSITION
- 26 Dec 2018 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 07 Dec 2018 — APPROVED FOR PUB - PRINCIPAL REGISTER